Proprio Vision

About:

Proprio uses machine learning, computer vision, and augmented reality user interfaces to improve the accuracy and efficiency of surgery.

Website: https://www.propriovision.com

Twitter/X: Proprio_Vision

Top Investors: Intel, Intel Capital, Bold Capital Partners, DCVC, Liquid 2 Ventures

Description:

Proprio is a Seattle-based company utilizing machine learning, automated intelligence, and mixed-reality user interfaces to develop a next-generation surgical navigation and imaging platform to improve surgical accuracy, simplify surgical workflows, and improve patient outcomes. The solution they’re building supplants surgical microscopes, navigation systems, loupes, and screens, replacing surgical microscopes alone wouldn’t be a compelling enough goal for them though. Their greater vision is to move medicine out of the past and into a future that fully leverages not only existing technologies, like AR/VR but one where medical innovation can move at the pace of software development in other industries. In order to realize that future, they have to move away from a dependency on ground glass, in the case of microscopes, and toward a focus on software and data, and leverage the emerging capabilities of computer vision and machine learning to enhance the combined performance of humans and computers.

Total Funding Amount:

$85.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)propriovision.com

Founders:

Gabriel Jones, Joshua Smith, Samuel Browd

Number of Employees:

11-50

Last Funding Date:

2023-07-27

IPO Status:

Private

© 2024 MyAiNote.com